Is emphysema a risk factor for pneumothorax in CT-guided lung biopsy? by Nobuhiro Asai et al.
a SpringerOpen Journal
Asai et al. SpringerPlus 2013, 2:196
http://www.springerplus.com/content/2/1/196RESEARCH Open AccessIs emphysema a risk factor for pneumothorax in
CT-guided lung biopsy?
Nobuhiro Asai1,3*, Yasutaka Kawamura2, Ikuo Yamazaki2, Keiji Sogawa2, Yoshihiro Ohkuni1, Toshihiro O’uchi2,
Akihito Kubo3, Etsuro Yamaguchi3 and Norihiro Kaneko1Abstract
Introduction: Computed tomography (CT)-guided lung biopsy is commonly used to make a histological diagnosis
for pulmonary lesions. Its most common complication is pneumothorax. While it is thought that CT-guided lung
biopsy should be avoided in patients with emphysema, however, there is no scientific report documenting the
relationship the occurrence of pneumothorax and the severity of emphysema.
Purpose and methods: To investigate the relationship between the severity of emphysema and the frequency of
pneumothorax, we retrospectively reviewed all the patients who received CT-guided lung biopsy. Severity of
emphysema is evaluated by Goddard classification, a visual scale by which areas of vascular disruption and low
attenuation value were scored for each lung field of high resolution CT.
Patients’ characteristics, prognostic accuracy of this method, size and location of the lesion, length of
intrapulmonary biopsy paths, and frequency of complications such as pneumothorax or intrapulmonary
hemorrhage were evaluated.
Results: One hundred-two patients (69 males and 33 females) received 102 procedures. Diagnostic accuracy was
90.2%. Pneumothorax occurred in 41 of 102 biopsies (40.2%). Chest tube placement was required in 3 out of the 41
cases (7.3%) complicated by pneumothorax (2.9% of all the biopsies). The longer lesion depths from pleura were,
the more frequently pneumothorax occurred (6.67 vs 3.66 mm, p=0.019). No correlation was found between
location of lesions and frequency of pneumothorax. No significant differences of COPD staging or LAA score were
seen between the patients with and without pneumothorax (5.73 vs 4.32 points, p=0.339).
Conclusion: We suggest that severity of emphysema such as stage I or II COPD may not be related to the
frequency of pneumothorax.
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Computed tomography (CT)-guided lung biopsy is com-
monly used to make a histological diagnosis for pulmon-
ary lesions (Harter et al. 1983; Li et al. 1996; Klein &
Zarka 1997). The diagnostic accuracy of this method has
been reported and ranges from 64-97% (Klein & Zarka
1997; Hiraki et al. 2009; Tomiyama et al. 2006). In gen-
eral, CT-guided lung biopsy is regarded as a safe proced-
ure, although some serious complications such as* Correspondence: nobuhiro0204@hotmail.com
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of malignant cells are rarely experienced (Sinner 1976;
Ibukuro et al. 2009; Perlmutt et al. 1989). The most
common complication related to CT-guided lung biopsy
is pneumothorax, followed by hemorrhage. The rate of
pneumothorax reported varies widely and ranges from
8-69%, depending on location or size of the lesion, nee-
dle used, as well an experience of the operator (Li et al.
1996; Klein & Zarka 1997; Hiraki et al. 2009; Tomiyama
et al. 2006; Perlmutt et al. 1989; Khan et al. 2008).
Some physicians and statements have demonstrated
that emphysema is a risk factor for pneumothorax
(Tomiyama et al. 2006; National Institute of Health,
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Consensus of Percutaneous Lung Needle Biopsy 2007).
Actually, physicians are reluctant to perform CT-guided
lung biopsy in some cases with outstanding emphysema
revealed by chest CT hesitating to perform it because
severe pneumothorax needing chest tube drainage is
likely to occur. Actually, we hesitate as others would in
performing CT-guided lung biopsy in cases in which we
consider that severe pneumothorax requiring a chest
tube drainage would likely occur. Although transbron-
chial lung biopsy (TBLB) is commonly used in diagnos-
ing lung cancer, it is often not sufficient to make a
diagnosis of peripheral or small lesions. Currently, TBLB
with concurrent navigation systems shows a high
accuracy in diagnosis of peripheral and small lesions
compared with conventional methods (Arenberg 2009;
Makris et al. 2007; Gildea et al. 2006). However, it does
not make CT-guided lung biopsy unnecessary in terms
of a diagnostic accuracy. While the notion that emphy-
sema is a risk factor for pneumothorax is thought to
be reasonable among physicians, the correlation be-
tween the rate of pneumothorax and emphysema has
never previously been reported. For the purpose of
examining the relationship between the frequency of
pneumothorax and the severity of emphysema using
the Goddard classification which reflects the severity
of COPD, we retrospectively analyzed all the patients
who underwent CT-guided needle biopsy at our insti-
tution from January 2006 to April 2011. This is the
first report demonstrating the correlation of the
frequency of pneumothorax with the severity of
emphysema.
Patients and methods
We had sought and obtained approval from our institute
to use patients’ records for this study. All patients’ confi-
dentiality was maintained.
Eligibility
All patients who underwent CT-guided lung biopsy in
our institution from April 2006 to August 2011 were
eligible in this study. One hundred four CT-guided lung
biopsies were performed in 102 patients. Informed con-
sent was obtained before the procedure in all cases. All
the examinations were performed strictly based on clin-
ical indications alone.
The decision for performing lung biopsy was made in
the following cases:
The indication for the lung biopsy was made as
follows.
1) Suspected malignancy on the basis of CT
morphologic criterion such as shape and
margination.2) Negative bronchofiberopic examination with any
reasons.
3) Lesion initially classified as benign but showed
increase in size during follow-up examination.
4) Lesion initially regarded as benign or inflammatory
but did not respond to therapy.
One to three biopsy procedures were done per time
depending on specimens obtained or on whether com-
plication occurred or not by the procedure. Patients’
background, prognostic accuracy of this method, size
and location of the lesion, length of intrapulmonary bi-
opsy paths, frequency of complications such as pneumo-
thorax or intrapulmonary hemorrhage were evaluated.
In addition, the frequency of pneumothorax and chest
tube placement were analyzed in terms of the scores by
Goddard classification or severity of chronic obstructive
pulmonary disease (COPD) as well as various variables
such as size and location of lesion, length between the
lesion and the thoracic wall, and whether interstitial
pneumonia exit or not.
Procedure
Patients were placed in the prone, spine, or lateral de-
cubitus positions, depending on the location of the le-
sion to provide the shortest route for lung biopsy.
Biopsies were performed to avoid ribs, bullae, vessels
and fissures. Normal platelet counts and coagulation pa-
rameters such as prothrombin time or activated pro-
thrombin time of all the patients were confirmed within
3 days before the procedure and made sure that they
had taken no anticoagulants in the previous 1-2 weeks.
At the site of puncture, 10ml 1% xylocain was adminis-
tered subcutaneously as local anesthesia. After skin inci-
sion, all biopsies were performed with an 18-gauge
coaxial needle system. The needle was manually pushed
into the lung lesion and biopsy was repeated in the same
session. Specimens obtained were immediately immersed
in 10% formalin solution and sent for examination to
the staff pathologist of our hospital. After the procedure,
a chest CT scan was routinely done to detect pneumo-
thorax or intrapulmonary hemorrhage. Patients with
asymptomatic pneumothorax or intrapulmonary hemor-
rhage were treated conservatively with monitoring of
vital signs and follow-up chest radiographs to confirm
stability. A chest tube was inserted for drainage in pa-
tients who had pneumothorax with signs of respiratory
distress or shortness of breath. All the patients were
admitted to the hospital and discharged on the next day
in an uneventful course.
Evaluation of COPD
High resolution computed tomography (HRCT) was
performed for all the patients to detect low attenuation
Figure 1 Shows the relationship between LAAs and the scores of Goddard classification. a. showing 0 to 25 % of LAA in the lung,
Goddard classification 1. b. showing 25 to 50 % of LAA in the lung, Goddard classification 2. c. showing 50 to 75 % of LAA in the lung,
Goddard classification 3. d. showing 75 to 100 % of LAA in the lung, Goddard classification 4.
Table 1 Relationship between occurrence of pneumothorax and clinical factors evaluated.
Clinical factors Patients with pneumothorax Patients without pneumothorax p value
No. (%) 41 (40.2%) 61 (59.8%) NS
Age, yr 72.3 (55-84) 68.3 (42-86) NS
Male/Female 30/11 39/22 NS
Location of lesion
Upper or middle 22 33 NS
Lower 19 28
Lesion size, mm 23.6 (10-65.8) 32.3 (10-85) 0.006
Lesion depth, mm 6.67 (0-46.6) 3.66 (0-39) 0.019
COPD staging
I 17 17 0.199
II 8 4 0.062
III 1 0 0.402
IV 0 0 1.000
Unknown 5 15 0.137
LAA (±SD) 5.73 (±5.6) 4.79 (±4.32) 0.339
LAA in puncture route (±SD) 0.73 (±0.95) 0.77 (±0.86) 0.831
Data are presented as mean (range) or No. LAA was scored by Goddard classification.
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Table 2 Relationship between frequency of pneumothorax and lesion depth from pleura.
Lesion depth
(mm)




0 57 15 0 26.3
< 10 24 14 1 58.3
10-15 6 3 0 50
15 < 15 9 2 60
Asai et al. SpringerPlus 2013, 2:196 Page 4 of 6
http://www.springerplus.com/content/2/1/196area (LAA) before CT-guided lung biopsy. Severity of
COPD is evaluated by Goddard classification Goddard
et al. (1982), which is a visual scale that area of vascular
disruption and low attenuation value were scored for
each lung field. Zero represented no abnormality; 1 was
given for up to 25%, 2 for up to 50%, 3 for up to 75%,
and 4 for total involvement or almost total absence of
normal lung tissue. There was a possible score of 24 as
maximum for each patient. HRCT was assessed by a
pulmonologist and a radiologist (Figure 1).
Statistical analysis
Statistical analysis was examined using Statview. Differ-
ences were considered significant when P value was less
than 0.05.
Results
This study included 69 male (67.6%) and 33 female
(32.4%). The mean age of the population was 69.9 years
(range, 42 to 86 years). The mean size of the lesions was
28.8 mm (range 10 to 85 mm). The lesion was in the
upper and middle lung field in 55 patients (53.9%) and
in the lower lung field in 47 patients (46.1%). The mean
length from pleura to the lesion was 5.6 mm (SD±9.6,
range 0 to 46.6 mm). In terms of scores by Goddard
classification, the average point was 5.2 (SD±4.9, range 0
to 24). Table 1 shows variables in 102 patients classified
into two groups: those with and without pneumothorax.
Pneumothorax occurred in 41 of 102 biopsies (40.2%).
Chest tube placement was required in 3 out of the 41
cases (7.3%) complicated by pneumothorax (2.9% of all
biopsies). The mean size of the lesions in the patients
with pneumothorax was smaller than those without
(p=0.006). The longer lesion depths from pleura were,
the more frequently pneumothorax occurred as shown
in Table 2 (p=0.019), while no statistical significance wasTable 3 Diagnostic yield of CT-guided percutaneous lung bio
Diagnostic Yield ≦10mm (n=2) 10-20mm (n=28)
True-positive results 0 16
True-negative results 1 7
False-positive results 0 0
False-negative results 0 0
Nondiagnostic results 1 5seen. No correlation was found between location of le-
sions and frequency of pneumothorax. Forty-seven of
the 102 patients (46.1%) were diagnosed as COPD by
spirometry. Forty-six of the 47 patients (97.9%) were
classified as COPD I and II. Twenty patients (19.6%) did
not undergo pulmonary function test although they have
a heavy smoking history. Thirty-five of the 82 patients
(42.7%) did not fulfill the criteria of COPD by the result
of the pulmonary function test. No significant differ-
ences of COPD staging or LAA were seen between the
patients with and without pneumothorax. In terms of
Goddard Classification scores for the CT slices of punc-
ture tract, there was no significant difference in the two
groups.
Diagnostic yield
The specimens obtained from the 102 lesions were
adequate for diagnosis. The diagnostic yields for each
lesion size and overall are shown in Table 3. Non-
diagnostic results were obtained in 10 of the 102 lesions.
Malignant and benign diagnosis were obtained by biopsy
in 72 and 21 lesions, respectively. A final diagnosis of
malignancy was made in 77 lesions. These malignant
diagnoses were confirmed by the surgical specimens
(n=72), other examinations including lymph node biopsy
(n=1) and ultrasoundsonography-guided lung biopsy
(n=3), or obvious post procedural malignant processes
(n=1). A final diagnosis of benign disease was made in
25 lesions and based on the characteristics of the surgi-
cal specimen (n=2), lesion regression with conservative
or medical therapy (n=2), or stable lesion size for at least
1 years (n=21). A final diagnosis of benign disease was
made in 25 lesions. They were confirmed by microscopic
findings of the surgical specimen (n=2), lesion regression
with conservative or medical therapy (n=2), or stable
lesion size for at least 1 years (n=21).psy
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value and negative predictive value for the diagnosis of
malignancy were 89.5% (68 of 76 lesions), 88% (22 of 25
lesions), 100% (68 of 68 lesions) and 75.6% (25 of 33
lesions), respectively. The diagnostic accuracy was 90.2%
(92 of 102 lesions).
Discussion
It has been reported that 30 % of elderly patients who
are more than 65 years with lung cancer are complicated
with COPD (van de Schans et al. 2007; Maas et al.
2003). Clinicians tend to hesitate to perform CT-guided
lung biopsy in patients with outstanding LAA because
they are afraid of severe pneumothorax. TBLB is com-
monly used in the diagnosis of lung cancer. While navi-
gation systems can increase a diagnostic accuracy for
small lesions as early stage lung cancer (Arenberg 2009;
Makris et al. 2007; Gildea et al. 2006), it is not accurate
enough to replace CT-guided lung biopsy.
It has previously been thought that patients with poor
pulmonary functions, especially elderly, had no choice in
receiving treatment because they were not thought to be
eligible for operation. Ando, et al. previously reported
that stereostatic radiotherapy (SRT) is not inferior to
surgical operation in the treatment of the elderly with
stage I lung cancer (Ando et al. 2010). Nowadays, the
patients who cannot receive the operation for early stage
lung cancer could have an occasion to treat by SRT with
acceptable complication rates (Ando et al. 2010). More-
over, in Japan, mass screening trials for COPD patients
to make a diagnosis as lung cancer by CT scan has been
ongoing since 2008, that is, it is presumed that more pa-
tients with a small lesion will be found and referred to
us. Therefore, CT-guided lung biopsy is expected to be
performed more frequently for diagnosis of the small
lesions as early stage lung cancer. Thus, the indication
for CT-guided lung biopsy for patients with emphysema
should be established. This is the first report in terms of
the relationship between the risk for pneumothorax and
COPD or emphysema.
In diagnosing a small lesion as lung cancer, avoiding
performing CT-guided lung biopsy for patients with an
outstanding emphysema would be reasonable, since cli-
nicians are very afraid of severe pneumothorax that
would require chest tube drainage. We suggest that
COPD staging of I and II, or high scores of LAA by
Goddard classification might not be at risk for pneumo-
thorax. To our surprise, pneumothorax did not occur in
patients with higher score of LAA, even though no sig-
nificant difference in the extent of LAA was seen in the
two groups, namely between patients with and without
pneumothorax as shown in Table 1. One possible ex-
planation is that operators performed more carefully in
patients with outstanding LAA. . For cases with lungfields with LAA scores ≧3, CT-guided lung biopsy was
not performed in this study. It might be necessary to in-
vestigate the relationship between the Goddard classifi-
cation of the CT-guided lung biopsy tract and the
occurrence of pneumothorax
There are some limitations as follows. First, this is a
retrospective study in a very small population. Second,
patients with COPD staging of III and IV are not in-
cluded in this study. Selection bias could possibly exist.
Clinically, severe and very severe COPD patients should
also be analyzed for the procedure with acceptable toler-
ability. Third, there might be both interobserver and
intraobserver differences in scoring LAA scores.
In conclusion, we suggest that COPD and LAA by
Goddard classification may not be related to the fre-
quency of pneumothorax. CT-guided lung biopsy could
be performed in patients with COPD staging of I and II
with acceptable tolerability. More patients with COPD
should be analyzed to make an indication of CT-guided
lung biopsy for patients with severe emphysema.
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